Staphylococcus Aureus Bacteremia Clinical Trials
32 clinical trials for Staphylococcus Aureus Bacteremia across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia — RECRUITING · PHASE4
- Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia — RECRUITING · PHASE2
- Staphylococcus Aureus Network Adaptive Platform Trial — RECRUITING · PHASE4
- PK/PD of Cefadroxil in Staphylococcus Aureus Bacteremia, a preliminary study — RECRUITING · PHASE2
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia — RECRUITING · PHASE4
- Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? — RECRUITING · PHASE4
- Evaluating Simplified Layered Consent for Clinical Trials — RECRUITING · NA
- Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia — RECRUITING
- Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia:
A randomized, non-blinded, non-inferiority interventional study — TERMINATED · PHASE4
- Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia — COMPLETED · PHASE1
- Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. — COMPLETED · PHASE1
- SAFE study — TERMINATED · PHASE3
- Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia — NOT_YET_RECRUITING · PHASE4
- Staphylococcus Aureus Bacteraemia (SAB)-Support-Study — COMPLETED · NA
- Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia — ACTIVE_NOT_RECRUITING
- Infectious Diseases Consultation Servives in combination with Antibiotic Stewardship Activities in German Non-University Hospitals — OTHER
- Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia — OTHER · PHASE3
- Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study). — OTHER · NA
- Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia — COMPLETED · PHASE3
- Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase — TERMINATED · PHASE3
- 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia — OTHER · NA
- The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia — COMPLETED · NA
- Oritavancin for Staphylococcus Aureus Infections in Opioid Users — WITHDRAWN · PHASE4
- Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia — COMPLETED · PHASE2
- Phase IIa Clinical Study of N-Rephasin® SAL200 — TERMINATED · PHASE2
- Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia — OTHER · PHASE4
- Bloodstream Infections in Patients With Rheumatoid Arthritis — COMPLETED
- Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology — COMPLETED
- Staphylococcus Aureus Bacteraemia in Adults — OTHER
- Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia — COMPLETED · PHASE4
- Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia — OTHER · NA
- Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) — COMPLETED · PHASE2
Refine this search